Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating Expenses
Research and development	$ 3,732	$ 1,957	$ 8,717	$ 5,605
General and administrative	5,834	5,043	16,769	13,210
Depreciation and amortization	180	126	488	363
Total operating expenses and loss from operations	9,746	7,126	25,974	19,178
Other (income) expenses
Interest income	(2,309)	0	(6,077)	0
Interest expense, net of capitalized interest	0	0	0	2,839
Change in fair value of derivatives	(1,129)	0	(1,725)	1,426
Change in fair value of warrants liability	1,419	(13,481)	(15,610)	7,363
Change in fair value of earnout liability	(15,147)	(21,511)	(63,561)	(67,008)
Other income, net	(879)	(27)	(1,577)	(651)
Total other income, net	(18,045)	(35,019)	(88,550)	(56,031)
Net income	8,299	27,893	62,576	36,853
Other comprehensive income (loss)
Unrealized (loss) on marketable securities	(1,403)	0	(10,783)	0
Foreign currency translation adjustment, net of tax	(7,253)	(1,068)	(8,061)	24
Total comprehensive income (loss)	$ (357)	$ 26,825	$ 43,732	$ 36,877
Net income per share, basic (in dollars per share)	$ 0.06	$ 0.20	$ 0.46	$ 0.41
Net income per share, diluted (in dollars per share)	$ 0.06	$ 0.20	$ 0.44	$ 0.39
Weighted-average common shares outstanding, basic (in shares)	138,061,829	136,749,956	137,348,180	89,244,640
Weighted-average common shares outstanding, diluted (in shares)	142,197,014	141,239,965	142,134,560	94,029,056